Publication

Article

CURE

Summer 2014
Volume13
Issue 2

Group Launches Global Initiative to Support Cancer Research

Author(s):

Katherine Lagomarsino

Project: EveryChild is collecting biologic samples, such as blood, tissue and other specimens, from children undergoing treatment.

The world's largest organization dedicated to childhood and adolescent cancer research is engaging more than 200 pediatric cancer programs around the U.S. to participate in collecting biologic samples, such as blood, tissue and other specimens, from children undergoing treatment. Called Project:EveryChild, the purpose of the Children’s Oncology Group (COG) initiative is to develop new treatments for childhood cancers that are both common and rare, including leukemias, lymphomas, solid tumors and tumors of the central nervous system. The information gleaned from these biospecimens will be entered in a secure database that can be accessed by researchers worldwide with the hope they can utilize it to discover more effective and less toxic treatment options, as well as cures.

Articles in this issue
New Guidelines Recommend Genetic Testing for Lynch Syndrome
National Women's Survivors Convention
Ruling Grants Patients Direct Access to Lab Results
A Spice for Life
Group Launches Global Initiative to Support Cancer Research
Chemo Brain Doc Notes App
Survivorship Issues Can't Be Ignored
Husband's Guide to Breast Cancer: A Complete & Concise Plan for Every Stage
Bone Basics
Assessing the Risk
Finding the Positives in Negative Results
Support for Chemotherapy-Induced Peripheral Neuropathy
Avoid Carcinogens, Not the Grill This Summer
Transitioning Care: A Caregiver's Role
The High Cost of Hospital Readmissions
Related Videos
Image of a woman with short brown hair, wearing glasses.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black suit and tie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with a brown hair tied into a bun.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Image of a man with brown hair.
Image of a woman with short brown hair and glasses.
Image of a woman with short brown hair and glasses.
Image of a man with brown hair and a suit and tie.
Related Content
FDA approves Ryoncil for children with GVHD.
December 18th 2024

Ryoncil Receives FDA Approval for Children With GVHD

Darlene Dobkowski, MA
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a man with dark hair and a dark goatee, wearing rectangular glasses.
December 18th 2024

A Holiday Poem: Who Says Cancer Doesn’t Rhyme?

Burt Rosen
The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Illustration of cross hairs on cancer in the blood.
December 16th 2024

Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL

Chris Ryan
Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.
Image of a patient talking to a nurse.
December 15th 2024

An Extraordinary Healer Inside and Out

Colleen Bruen, RN, BSN, BMTCN
Oncology nurse Denise always makes it a point to focus on the “big picture” for all of her patients with cancer.